Non-Medical Drugs Flashcards
Nalmefene (Revex) SE
May produce a prolonged withdrawal state (nausea, vomiting, piloerection, yawning)
Nalmefene (Revex) Class
Opiod antagonist
N-acetylcysteine (Mucomyst) class
Antioxidant
Cocaine class
CNS stimulant
LSD class
Schedule I Hallucinogen
Mescalineclass
Schedule I Hallucinogen
Psilocybin class
Schedule I Hallucinogen
Phencyclidine (PCP) class
Dissociative anesthetic
Marijuana (THC) class
Cannabinoid
Anandamide class
Endogenous cannabinoid
Dronabinol (Marinol) class
Synthetic THC
Nabilone (Cesamet) class
Synthetic THC
N-acetylcysteine (Mucomyst) MOA
Supplies sulfhydryl groups to glutathione; improves microcirculation, provides anti-inflammatory effect
Fomepizole (Antizol) MOA
Blocks alcohol dehydrogenase
Cocaine MOA
Blocks reuptake of dopamine, norepinephrine, and serotonin
LSD MOA
Agonist at 5HT2A receptors on Raphe cell body –> inhibition of Raphe Nuclei firing –> increased sensory input; partial dopamine agonist
Mescaline MOA
Agonist at 5HT2A receptors on Raphe cell body –> inhibition of Raphe Nuclei firing –> increased sensory input; partial dopamine agonist
Psilocybin MOA
Agonist at 5HT2A receptors on Raphe cell body –> inhibition of Raphe Nuclei firing –> increased sensory input; partial dopamine agonist
Phencyclidine (PCP) MOA
Antagonist of ion channel associated with NDMA receptor; agonist at mu opioid receptors
Amphetamines (Benzadrine) MOA
Indirect sympathomimetic (release biologic amines from nerve terminals in periphery and in CNS); dopamine most important
Marijuana (THC) MOA
Hits cannabinoid receptors (CB1, CB2: G-protein coupled receptors)
Anandamide MOA
Hits cannabinoid receptors (CB1, CB2: G-protein coupled receptors)
Dronabinol (Marinol) MOA
Hits cannabinoid receptors (CB1, CB2: G-protein coupled receptors)
Nabilone (Cesamet) MOA
Hits cannabinoid receptors (CB1, CB2: G-protein coupled receptors)
Nalmefene (Revex) Therapeutics
N-acetylcysteine (Mucomyst) Therapeutics
Acetaminophen overdose
Fomepizole (Antizol) Therapeutics
Methanol & ethylene glycol poisoning
Cocaine Therapeutics
Topical anesthetic, combined vasoconstrictor and local anesthetic
LSD Therapeutics
Schedule I hallucinogen; model hallucinogen against which all others compared; limited studies in psychoanalysis, alcoholism, autistic children, and terminal cancer patients
Mescaline Therapeutics